Toggle Main Menu Toggle Search

Open Access padlockePrints

De novo serine biosynthesis is protective in mitochondrial disease

Lookup NU author(s): Dr Amy VincentORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Abstract

© 2025 The AuthorsThe importance of serine as a metabolic regulator is well known for tumors and is also gaining attention in degenerative diseases. Recent data indicate that de novo serine biosynthesis is an integral component of the metabolic response to mitochondrial disease, but the roles of the response have remained unknown. Here, we report that glucose-driven de novo serine biosynthesis maintains metabolic homeostasis in energetic stress. Pharmacological inhibition of the rate-limiting enzyme, phosphoglycerate dehydrogenase (PHGDH), aggravated mitochondrial muscle disease, suppressed oxidative phosphorylation and mitochondrial translation, altered whole-cell lipid profiles, and enhanced the mitochondrial integrated stress response (ISRmt) in vivo in skeletal muscle and in cultured cells. Our evidence indicates that de novo serine biosynthesis is essential to maintain mitochondrial respiration, redox balance, and cellular lipid homeostasis in skeletal muscle with mitochondrial dysfunction. Our evidence implies that interventions activating de novo serine synthesis may protect against mitochondrial failure in skeletal muscle.


Publication metadata

Author(s): Jackson CB, Marmyleva A, Monteuuis G, Awadhpersad R, Mito T, Zamboni N, Tatsuta T, Vincent AE, Wang L, Khan NA, Langer T, Carroll CJ, Suomalainen A

Publication type: Article

Publication status: Published

Journal: Cell Reports

Year: 2025

Volume: 44

Issue: 5

Online publication date: 27/05/2025

Acceptance date: 25/04/2025

Date deposited: 27/05/2025

ISSN (print): 2639-1856

ISSN (electronic): 2211-1247

Publisher: Elsevier B.V.

URL: https://doi.org/10.1016/j.celrep.2025.115710

DOI: 10.1016/j.celrep.2025.115710

Data Access Statement: All data are available upon reasonable request from the lead contact. Metabolomics data are provided as supplemental information. No original code has been generated for this study. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Henry Wellcome Fellowship
the Novartis Foundation for Medical-Biological Research
the Academy of Finland

Share